UCI Professor Zhibin Guan Joins NuGene Advisory Board

IRVINE, Calif., March 30, 2015 /PRNewswire/ -- NuGene International, Inc. ("NuGene") (OTCQB: NUGN), announced today that its subsidiary corporation, NuGene BioPharma, Inc. has added another internationally recognized researcher to its advisory board.

Dr. Guan is an internationally recognized researcher in bio-inspired materials and bio-materials fields. After finishing his college education at Peking University, China, Professor Guan received his Ph.D. degree from the University of North Carolina, Chapel Hill. Following a postdoctoral training at the California Institute of Technology (Caltech), he spent five years working at the Central Research and Development Laboratory of DuPont as a Senior Research Scientist.

He became a faculty member with the Chemistry, Biomedical Engineering, and Chemical Engineering and Materials Science departments of the University of California, Irvine in 2000 and was promoted to full professor in 2006.

Professor Guan is recognized for his contributions to macromolecular chemistry, bio-inspired materials design, and functional bio-materials for tissue engineering and gene delivery. He is the author of more than 80 publications in peer-reviewed journals including Science, Nature Materials, Nature Biotechnology, Nature Chemistry, etc.

Dr. Guan is the inventor of more than a dozen patents, and his work has been cited by others over 5000 times. He has received numerous awards including the Humboldt Bessel Research Award, the Camille Dreyfus Teacher-Scholar Award, the NSF CAREER Award, and the Beckman Young Investigator Award. In 2008, he was elected a Fellow of the American Association for the Advancement of Science.

"We continue to attract and recruit special talents to our advisory board," stated NuGene International's CEO Ali Kharazmi when announcing the addition. "His knowledge of functional bio-materials for tissue engineering and gene delivery is a perfect fit with our current board of advisors. As we seek to advance the stem cell enhanced cosmeceutical and pharmacological fields, Dr. Guan's expertise in these areas will be critical."

About NuGene International, Inc.

NuGene International, Inc. specializes in developing, manufacturing and marketing proprietary regenerative cosmeceutical and pharmaceutical products based on adipose derived human stem cell and human stem cell media.  The US Department of Health and Human Services calls regenerative medicine the "next evolution of medical treatments".  The regenerative medical market which includes cosmeceuticals and pharmaceuticals was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Services Global Cosmeceuticals Market report.  NuGene's cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue.  NuGene's exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations.  The company has two patents pending covering 15 unique applications and inventions.  NuGene's goal is to leverage its extensive knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products in addition to pharmaceutical products based on the same regenerative science platform.

Forward-Looking Statements

This release contains forward-looking statements. Actual results may differ from those projected due to a number of risks and uncertainties, including, but not limited to the possibility that some or all of the matters and transactions considered by NuGene International may not proceed as contemplated, and by all other matters and assumptions specified in NuGene's filings with the Securities and Exchange Commission, especially those risks and other matters described under "Risk Factors" within NuGene's Form 8-K filed with the Commission on January 6, 2015. These statements are made based upon current expectations that are subject to risk and uncertainty. NuGene does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information.

Investor/ Media Relations:
Chris Rosgen
Capital Market Relations
(949)481-9739

Logo - http://photos.prnewswire.com/prnh/20150303/179172LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/uci-professor-zhibin-guan-joins-nugene-advisory-board-300057553.html

SOURCE NuGene International, Inc.